Effectiveness clears the path for selling stockholders to immediately sell into the market, creating severe overhang. Monitor for any Form 4 filings or prospectus supplements indicating actual sales. Given the company's precarious financial state, any material insider selling would be a further negative signal.
Price Chart
Executive Summary
SEC declared Catheter Precision's S-1 registration statement effective, allowing selling stockholders to resell up to 68 million shares. Filing document content was unavailable — analysis based on cross-filing context and metadata. The effectiveness triggers massive potential dilution (~96% of post-issuance shares vs. current 2.7M outstanding) for a company with a going-concern opinion and negligible cash.
Key Facts
- S-1 registration declared effective by SEC (form EFFECT)
- Registration covers resale of 68,067,042 shares by selling stockholders
- Shares issuable on conversion of Series C-1/C-2/C-3/D/J convertible preferred stock and Series M warrants
- Company has going-concern opinion from auditor, ~$0.4M cash as of March 31, 2026, and $18.5M working capital deficit
- Two business segments (cardiac electrophysiology and private aviation) with negligible revenue
Financial Impact
Potential dilution of ~96% of post-issuance shares from current 2.7M outstanding; as of last filing, cash <$0.5M and working capital deficit >$18M
Risk Factors
- Massive dilution from potential conversion and resale of up to 68M shares
- Going-concern risk with minimal cash and large working capital deficit
- Low liquidity and market cap ($3M) exacerbate price impact of any selling
Market Snapshot
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $1.00 $0.8200 | ▲ +18.00% | ▲ +16.51% | $0.6500 (+35.00%) |
Oct 5, 2026 22d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 24d ago | 8-K | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 24d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Sep 28, 2026 28d ago | Press Release | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Sep 25, 2026 4w ago | 8-K | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Aug 27, 2026 8w ago | Press Release | $0.2027 $0.1966 | ▼ −3.01% | ▼ −3.28% | $0.6500 (+220.67%) |
Aug 11, 2026 10w ago | Press Release | $0.2900 $0.2229 | ▼ −23.14% | ▼ −22.73% | $0.6500 (+124.14%) |
Aug 4, 2026 11w ago | Press Release | $0.2760 $0.2930 | ▲ +6.16% | ▲ +6.26% | $0.6500 (+135.51%) |
Jul 13, 2026 15w ago | EFFECT | $0.6504 $0.5020 | ▲ +22.82% | ▲ +21.87% | $0.6500 (+0.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers